Published Date: 26 Apr 2023
The target population typically has better health than participants in health research studies, such as cancer screening trials (the "healthy volunteer" effect).
Read Full News1.
Acalabrutinib + Venetoclax Combo Earns FDA Nod for CLL
2.
Is Exercise an Effective Treatment for Prostate Cancer?
3.
Genetics and therapy type determine second cancer risk after childhood treatment, study finds
4.
Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer
5.
Treatment of Smoldering Myeloma Cuts Progression Rate in Half
1.
Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know
2.
Transformative Directions in Hematology in Clinical Decision-Making
3.
Understanding QSOFA: A Vital Tool for Recognizing Sepsis
4.
Recent Advances in Paroxysmal Nocturnal Hemoglobinuria Research: Promising Therapies on the Horizon
5.
Real-World Oncology Insights: CAR-T, Immunotherapy, PROs, and Digital Tools
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
2.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation